# North America Veterinary Care Market

> North America Veterinary Care Market Research Report Information By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, and Poultry), By Treatment Type (No Medicalization, Basic Medicalization, and Veterinary Care)–and North America Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.41%
- **2024:** $ 12.12 Billion
- **2025:** $ 12.58 Billion
- **2035:** $ 17.54 Billion
- **Key Players:** Mars Petcare (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Merck Animal Health (US), VCA Inc. (US), PetSmart (US), Nestle Purina PetCare (US), Idexx Laboratories (US)

**Report ID:** MRFR/HC/16219-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/north-america-veterinary-care-market-17747

---

## Market Summary

## **North America Veterinary Care Market Overview**

As per MRFR analysis, the North America Veterinary Care Market Size was estimated at 11.97 (USD Billion) in 2024. The North America Veterinary Care Market Industry is expected to grow from 12.79 (USD Billion) in 2025 to 23.12 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.80% during the forecast period (2025 - 2034). The growing perception of pets as family members is one of the major drivers driving the veterinary care market in North America. Industries are adopting Veterinary Care due to advancements in treatments and diagnostics.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Veterinary Care Market Trends**

### **Growing adoption of telemedicine in veterinary care is driving the market growth.**

The North American Veterinary Care market CAGR is expanding due to the adoption of telemedicine in veterinary care. It allows pet owners to connect with veterinarians remotely, seeking advice on non-emergency issues, discussing symptoms, and receiving guidance on basic healthcare. This trend has gained traction, especially with the advancements in digital communication technologies and the increased acceptance of virtual interactions. Telemedicine offers convenience for pet owners and helps address concerns promptly, reducing the need for physical visits unless absolutely necessary.

This trend has become even more prominent after the COVID-19 pandemic, where remote services gained prominence to ensure safety and adhere to social distancing measures.

Furthermore, the growth of the[Veterinary Care](../../../reports/veterinary-care-market-42285) market is influenced by a growing emphasis on preventive healthcare in North America. Pet owners increasingly recognize the importance of preventive measures to ensure their animals' well-being and avoid costly treatments for advanced illnesses. This shift in mindset has led to a raised demand for wellness exams, vaccinations, and preventive treatments. Veterinary clinics are responding by offering comprehensive preventive care packages, including regular check-ups, vaccinations, dental care, and nutritional counseling.

This proactive approach benefits the health of pets and contributes to the long-term sustainability of the veterinary care market by reducing the burden of treating advanced diseases. Thus driving the Veterinary Care market revenue.

## **Veterinary Care Market Segment Insights**

### **Veterinary Care Animal Type Insights**

The North America Veterinary Care market segmentation, based on animal type, includes Dogs, Cats, Cattle, Pigs, Horses, and Poultry. The dogs segment dominated the market. With a focus on canine health, veterinary care services cater to the diverse needs of dog owners. This specialized segment addresses preventive care, medical treatments, and overall dog well-being, reflecting the region's commitment to providing comprehensive and specialized veterinary services for this popular pet species.

### **Veterinary Care Treatment Type Insights**

The North America Veterinary Care market segmentation, based on treatment type, includes No Medicalization, Basic Medicalization, and Veterinary Care. The no medicalization category generated the most income. It signifies approaches in veterinary care that do not involve traditional medical interventions. It may include holistic or alternative therapies, preventive measures, or animal lifestyle adjustments, emphasizing non-medicalized strategies to maintain or enhance their well-being. This segment reflects a growing awareness and acceptance of non-conventional methods in veterinary care within the North American market.

**Figure 1: North America Veterinary Care Market, by Medicalization Type, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Veterinary Care Country Insights**

The rapid expansion of the advancements in diagnostics has resulted in a boom in demand for Veterinary Care in North America in recent years. In the United States, the largest market in the region, the rising pet ownership and increasing awareness about animal health drive the demand for veterinary services. Advanced medical technologies, diagnostic tools, and therapeutic options contribute to the market's expansion. Canada exhibits a similar trend, with a growing emphasis on preventive care and pet wellness. Both countries witness a surge in pet insurance adoption, fostering comprehensive healthcare.

While evolving, Mexico experiences a rising pet population and a gradual shift towards specialized veterinary services. The North American veterinary care market reflects a dynamic landscape shaped by evolving pet care preferences and advancing medical capabilities.

**Figure 2: NORTH AMERICA Veterinary Care MARKET SHARE BY REGION 2022 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Veterinary Care Key Market Players & Competitive Insights**

Leading market players are investing majorly in research and development to spread their product lines, which will help the Veterinary Care market grow even more. The participants also undertake various strategic activities to spread their footprint with new market developments, including product launches, contractual agreements, mergers and acquisitions, major investments, and collaboration with other organizations. The Veterinary Care industry must offer cost-effective items to spread and survive in a competitive and rising market climate.

Major players in the Veterinary Care market are attempting to raise market demand by investing in research and development operations includes Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), Heska Corporation. (US).

### **Key Companies in the Veterinary Care market include**

- Zoetis (US)
- Merck (US)
- Boehringer Ingelheim (Germany)
- [Elanco](https://www.elanco.com/en-us) (US)
- Ceva (France)
- Phibro Animal Health Corporation (US)
- Virbac SA (France)
- IDEXX Laboratories, Inc. (US)
- Neogen Corporation (US)
- Heska Corporation. (US)

### North America Veterinary Care Industry Developments

- **Q2 2024: Zoetis Announces FDA Approval of Librela® (bedinvetmab) for the Control of Osteoarthritis Pain in Dogs in the United States** Zoetis received FDA approval for Librela®, a monoclonal antibody therapy for the control of osteoarthritis pain in dogs, marking a significant regulatory milestone in the North American veterinary care market.
- **Q2 2024: Elanco Animal Health Announces U.S. Launch of Varenzin™-CA1, the First FDA-Approved Treatment for Nonregenerative Anemia in Cats with Chronic Kidney Disease** Elanco launched Varenzin™-CA1 in the U.S., the first FDA-approved treatment for nonregenerative anemia in cats with chronic kidney disease, expanding its feline therapeutics portfolio.
- **Q2 2024: IDEXX Laboratories Launches Next-Generation Catalyst® One Chemistry Analyzer for Veterinary Practices** IDEXX Laboratories introduced the next-generation Catalyst® One Chemistry Analyzer, offering enhanced diagnostic capabilities for veterinary clinics across North America.
- **Q3 2024: Mars Veterinary Health Opens New State-of-the-Art Veterinary Specialty and Emergency Hospital in Dallas, Texas** Mars Veterinary Health opened a new specialty and emergency hospital in Dallas, Texas, expanding its network of advanced veterinary care facilities in North America.
- **Q3 2024: Zoetis Completes Acquisition of PetMedix to Expand Monoclonal Antibody Platform for Companion Animals** Zoetis completed the acquisition of PetMedix, a UK-based biotech specializing in monoclonal antibody therapeutics for pets, strengthening its innovation pipeline in the North American market.
- **Q4 2024: Elanco Animal Health Appoints José Carlos González as President, North America** Elanco Animal Health announced the appointment of José Carlos González as President, North America, to lead the company’s regional operations and growth strategy.
- **Q4 2024: VCA Animal Hospitals Announces Partnership with PetDesk to Enhance Client Communication and Appointment Management** VCA Animal Hospitals partnered with PetDesk to implement advanced client communication and appointment management solutions across its North American clinics.
- **Q1 2025: Covetrus Launches New Veterinary Practice Management Software Platform, Covetrus Pulse™** Covetrus launched Covetrus Pulse™, a new cloud-based practice management software platform designed to streamline operations for veterinary practices in North America.
- **Q1 2025: Banfield Pet Hospital Opens 50th New Clinic in North America Since 2023** Banfield Pet Hospital celebrated the opening of its 50th new clinic in North America since 2023, reflecting ongoing expansion in veterinary care access.
- **Q2 2025: Zoetis Receives FDA Approval for Solensia® (frunevetmab) for the Control of Osteoarthritis Pain in Cats in the United States** Zoetis received FDA approval for Solensia®, a monoclonal antibody therapy for the control of osteoarthritis pain in cats, further expanding its U.S. companion animal therapeutics portfolio.
- **Q2 2025: Elanco Animal Health Announces $200 Million Investment to Expand Manufacturing Facility in Indiana** Elanco Animal Health announced a $200 million investment to expand its manufacturing facility in Indiana, aimed at increasing production capacity for veterinary medicines.
- **Q2 2025: IDEXX Laboratories Acquires ezyVet, a Leading Cloud-Based Veterinary Practice Management Software Provider** IDEXX Laboratories acquired ezyVet, a cloud-based veterinary practice management software provider, to enhance its digital solutions offering for North American veterinary practices.

## **Veterinary Care Market Segmentation**

### **Veterinary Care Animal Type Outlook**

- Dogs
- Cats
- Cattle
- Pigs
- Horses
- Poultry

### **Veterinary Care Medicalization Type Outlook**

- No Medicalization
- Basic Medicalization
- Veterinary Care

### **Veterinary Care Regional Outlook**

## Market Drivers

### Rising Pet Ownership

The North America Veterinary Care Market is experiencing a notable increase in pet ownership, which appears to be a significant driver of market growth. According to recent statistics, approximately 67% of U.S. households own a pet, translating to around 85 million families. This trend is likely to continue, as more individuals view pets as integral family members, thereby increasing the demand for veterinary services. The growing number of pets necessitates regular health check-ups, vaccinations, and emergency care, which in turn fuels the veterinary care market. Furthermore, the rise in pet ownership is accompanied by a shift towards premium pet care products and services, indicating a willingness among pet owners to invest in their pets' health and well-being. This evolving landscape suggests a robust future for the North America Veterinary Care Market.

### Regulatory Support and Standards

The North America Veterinary Care Market benefits from a robust regulatory framework that supports [animal health](https://www.marketresearchfuture.com/reports/animal-health-market-7163) and welfare. Government agencies, such as the U.S. Department of Agriculture and the Food and Drug Administration, play a crucial role in establishing standards for veterinary practices and animal care. These regulations ensure that veterinary services meet high-quality standards, fostering trust among pet owners. Additionally, initiatives aimed at improving animal welfare and public health are likely to drive demand for veterinary services. For example, programs promoting spaying and neutering, as well as vaccination campaigns, contribute to the overall health of the pet population. As regulatory support continues to evolve, it is expected to positively impact the North America Veterinary Care Market, encouraging responsible pet ownership and enhancing service delivery.

### Increased Focus on Preventive Care

The North America Veterinary Care Market is witnessing a paradigm shift towards preventive care, driven by a growing awareness of pet health among owners. Pet owners are increasingly recognizing the importance of regular veterinary visits for vaccinations, dental care, and wellness exams. This trend is reflected in the rising expenditure on preventive services, which is projected to account for a substantial portion of the overall veterinary care spending. In fact, data indicates that preventive care services could represent nearly 40% of total veterinary expenditures in the near future. This shift not only enhances the health and longevity of pets but also contributes to the financial stability of veterinary practices. As preventive care becomes a priority, the North America Veterinary Care Market is likely to experience sustained growth.

### Advancements in Veterinary Technology

Technological innovations are transforming the North America Veterinary Care Market, enhancing the quality and efficiency of veterinary services. The integration of telemedicine, advanced diagnostic tools, and electronic health records is becoming increasingly prevalent. For instance, the use of telehealth services allows veterinarians to consult with pet owners remotely, improving access to care. Moreover, the market for veterinary diagnostic equipment is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 8% in the coming years. These advancements not only streamline operations but also improve patient outcomes, as timely and accurate diagnoses lead to better treatment plans. As technology continues to evolve, it is likely to play a pivotal role in shaping the future of the North America Veterinary Care Market.

### Growing Demand for Specialized Veterinary Services

The North America Veterinary Care Market is increasingly characterized by a demand for specialized veterinary services, reflecting the evolving needs of pet owners. As pets are viewed more as family members, owners are seeking advanced care options, including specialty services such as oncology, cardiology, and dermatology. This trend is supported by the establishment of veterinary specialty hospitals and referral practices, which are becoming more common across the region. Market data suggests that the specialty veterinary services segment is expected to grow at a compound annual growth rate of over 10% in the coming years. This growth is indicative of pet owners' willingness to invest in specialized care, thereby driving the overall market. As the demand for specialized services continues to rise, the North America Veterinary Care Market is poised for significant expansion.

## Future Outlook

The North America Veterinary Care Market is projected to grow at a 3.41% CAGR from 2025 to 2035, driven by increasing pet ownership, advancements in veterinary technology, and rising consumer spending on pet health.

**New opportunities:**

- Telemedicine platforms for remote veterinary consultations. Subscription-based pet wellness plans for preventive care. Advanced diagnostic tools for early disease detection in pets.

By 2035, the market is expected to be robust, reflecting sustained growth and innovation.

## Segment Insights

### By Service Type: Preventive Care (Largest) vs. Emergency Care (Fastest-Growing)

The North America Veterinary Care Market showcases a diverse array of service types, with Preventive Care currently holding the largest market share. This segment focuses on wellness and routine check-ups, significantly influencing pet health and owner decisions. Following this, Emergency Care is rapidly gaining traction among service types, reflecting increasing pet ownership and the rising demand for immediate medical attention during health crises.

Preventive Care (Dominant) vs. Emergency Care (Emerging)

Preventive Care is characterized by routine veterinary visits and vaccinations aimed at maintaining optimal pet health. This segment plays a crucial role in early disease detection and health maintenance, fostering a close relationship between pet owners and veterinary professionals. In contrast, Emergency Care is marked by the need for rapid intervention, often during critical moments. The rising trend in pet ownership and the growing willingness of owners to seek immediate care for their pets drive this segment's growth. The advent of advanced veterinary surgical techniques and around-the-clock emergency facilities are key factors contributing to its emergence and increasing demand.

### By Animal Type: Companion Animals (Largest) vs. Livestock (Fastest-Growing)

In the North America Veterinary Care Market, the segment of Companion Animals holds the largest share. This dominance reflects the growing trend of pet ownership across the region, with families increasingly viewing pets as integral members of the household. Conversely, the Livestock segment is emerging as the fastest-growing area, driven by heightened awareness of animal health in agricultural practices and an increasing focus on food safety standards.

Companion Animals (Dominant) vs. Livestock (Emerging)

The Companion Animals segment remains the dominant force in the North America Veterinary Care Market, fueled by pet humanization trends and rising disposable incomes, which have led to increased spending on pet healthcare. Consumers prioritize preventative care, wellness services, and innovative treatments for their pets. On the other hand, the Livestock segment is emerging due to the growing emphasis on sustainable farming practices and advancements in veterinary technologies tailored for large animals. Livestock care is characterized by a focus on preventive health measures, vaccination programs, and herd health management to maximize productivity and animal welfare.

### By Product Type: Pharmaceuticals (Largest) vs. Vaccines (Fastest-Growing)

In the North America Veterinary Care Market, the 'Product Type' segment showcases a diverse distribution among its categories. Pharmaceuticals hold the largest share, reflecting their critical role in treating animal health issues. Vaccines, while constituting a smaller market share, are rapidly gaining traction due to increased awareness of disease prevention among pet owners, leading to their designation as the fastest-growing category. Medical devices, nutritional products, and pet food also contribute significantly, with each playing a unique role in the overall market landscape. The growth in this segment is primarily driven by advancements in veterinary technology and a rising emphasis on preventive care. The adoption of innovative pharmaceuticals and vaccines is propelled by the increasing incidences of zoonotic diseases and rising companion animal populations. Furthermore, the nutritional products category is witnessing a surge, aligning with the trends towards holistic pet care, while pet food segments are evolving to meet changing consumer preferences for premium and specialized diets.

Pharmaceuticals (Dominant) vs. Vaccines (Emerging)

Pharmaceuticals represent the dominant force within the North America Veterinary Care Market, characterized by a vast array of medications used for both therapeutic and preventive purposes. This segment is well-established, with a diverse range of anti-infectives, anti-inflammatories, and pain management products. Its strong market presence is supported by continuous research and development, aiming to enhance animal welfare and support veterinary practices. On the other hand, vaccines are emerging as a critical segment, driven by increasing consumer awareness and the demand for preventative healthcare solutions. The shift toward proactive health management in pets is fostering innovation in vaccine development, making this category not only fast-growing but also essential for ensuring the overall health of companion animals.

### By End User: Veterinary Clinics (Largest) vs. Animal Hospitals (Fastest-Growing)

In the North America Veterinary Care Market, Veterinary Clinics represent the largest segment in terms of market share. Following closely are Animal Hospitals, which have rapidly been gaining traction among pet owners and animal caretakers. Research Institutions, Pet Owners, and Government Agencies also play critical roles, with their shares reflecting various aspects of veterinary care such as research, pet health management, and regulatory services. Collectively, these segments underscore the diverse ecosystem that characterizes veterinary care in North America.

Veterinary Clinics (Dominant) vs. Animal Hospitals (Emerging)

Veterinary Clinics are a dominant force in the North America Veterinary Care Market, primarily due to their extensive reach and the trust they have built within communities. They offer a broad range of services including preventive care, diagnostics, and routine treatments. Alternatively, Animal Hospitals are emerging as a key player, propelled by increased pet ownership and a growing focus on specialized care. Unlike general clinics, these hospitals often provide advanced medical services such as surgery, emergency care, and specialty consultations. This shift towards comprehensive care has made Animal Hospitals a rapidly growing sector, capturing the interest of pet owners who seek more robust health management solutions for their animals.

## Regional Market Share Analysis

### US : Robust Growth and Innovation

The US veterinary care market holds a commanding share of 10.0% in North America, driven by increasing pet ownership and a growing focus on preventive care. Key growth drivers include advancements in veterinary technology, rising disposable incomes, and a heightened awareness of pet health. Regulatory support from agencies like the FDA ensures safety and efficacy in veterinary products, while infrastructure improvements in urban areas facilitate better access to veterinary services.

### Canada : Steady Growth Amid Challenges

Canada's veterinary care market, with a share of 2.12%, is experiencing steady growth, fueled by increasing pet adoption rates and a shift towards holistic pet care. Demand trends indicate a rise in specialty services and telemedicine, reflecting changing consumer preferences. Government initiatives aimed at improving animal health standards and welfare are also pivotal in shaping the market landscape, although challenges such as regulatory hurdles persist.

## Competitive Benchmarking

The Veterinary Care Market in North America is characterized by a dynamic competitive landscape, driven by increasing pet ownership, rising awareness of animal health, and advancements in veterinary technology. Key players such as Mars Petcare (US), Zoetis (US), and Elanco Animal Health (US) are strategically positioned to leverage these growth drivers. Mars Petcare (US) focuses on innovation in pet nutrition and health solutions, while Zoetis (US) emphasizes research and development in pharmaceuticals and diagnostics. Elanco Animal Health (US) is actively pursuing partnerships to enhance its product offerings, collectively shaping a competitive environment that prioritizes innovation and customer-centric solutions.
The market structure appears moderately fragmented, with a mix of large corporations and smaller specialized firms. Key players are employing various business tactics, such as localizing manufacturing and optimizing supply chains, to enhance operational efficiency. This collective influence of major companies fosters a competitive atmosphere where agility and responsiveness to market demands are crucial for success.
In December 2025, Zoetis (US) announced a strategic partnership with a leading technology firm to develop AI-driven diagnostic tools for veterinary practices. This move is significant as it positions Zoetis (US) at the forefront of technological innovation, potentially improving diagnostic accuracy and streamlining veterinary workflows. The integration of AI into veterinary care could enhance service delivery and patient outcomes, reflecting a broader trend towards digital transformation in the industry.
In November 2025, Elanco Animal Health (US) launched a new line of sustainable pet care products aimed at reducing environmental impact. This initiative aligns with growing consumer demand for eco-friendly solutions and demonstrates Elanco's commitment to sustainability. By prioritizing environmentally responsible practices, Elanco (US) not only differentiates itself in a competitive market but also appeals to a conscientious consumer base increasingly concerned about sustainability.
In October 2025, Mars Petcare (US) expanded its veterinary clinic network through the acquisition of several independent practices across the Midwest. This strategic expansion enhances Mars Petcare's service capabilities and market reach, allowing for a more integrated approach to pet health. Such acquisitions are indicative of a trend where larger players seek to consolidate their presence in local markets, thereby increasing their competitive edge.
As of January 2026, current trends in the Veterinary Care Market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of agility and responsiveness in meeting the evolving needs of pet owners and veterinary professionals.

## Recent News & Developments

- **Q2 2024: Zoetis Announces FDA Approval of Librela® (bedinvetmab) for the Control of Osteoarthritis Pain in Dogs in the United States** Zoetis received FDA approval for Librela®, a monoclonal antibody therapy for the control of osteoarthritis pain in dogs, marking a significant regulatory milestone in the North American veterinary care market.
- **Q2 2024: Elanco Animal Health Announces U.S. Launch of Varenzin™-CA1, the First FDA-Approved Treatment for Nonregenerative Anemia in Cats with Chronic Kidney Disease** Elanco launched Varenzin™-CA1 in the U.S., the first FDA-approved treatment for nonregenerative anemia in cats with chronic kidney disease, expanding its feline therapeutics portfolio.
- **Q2 2024: IDEXX Laboratories Launches Next-Generation Catalyst® One Chemistry Analyzer for Veterinary Practices** IDEXX Laboratories introduced the next-generation Catalyst® One Chemistry Analyzer, offering enhanced diagnostic capabilities for veterinary clinics across North America.
- **Q3 2024: Mars Veterinary Health Opens New State-of-the-Art Veterinary Specialty and Emergency Hospital in Dallas, Texas** Mars Veterinary Health opened a new specialty and emergency hospital in Dallas, Texas, expanding its network of advanced veterinary care facilities in North America.
- **Q3 2024: Zoetis Completes Acquisition of PetMedix to Expand Monoclonal Antibody Platform for Companion Animals** Zoetis completed the acquisition of PetMedix, a UK-based biotech specializing in monoclonal antibody therapeutics for pets, strengthening its innovation pipeline in the North American market.
- **Q4 2024: Elanco Animal Health Appoints José Carlos González as President, North America** Elanco Animal Health announced the appointment of José Carlos González as President, North America, to lead the company’s regional operations and growth strategy.
- **Q4 2024: VCA Animal Hospitals Announces Partnership with PetDesk to Enhance Client Communication and Appointment Management** VCA Animal Hospitals partnered with PetDesk to implement advanced client communication and appointment management solutions across its North American clinics.
- **Q1 2025: Covetrus Launches New Veterinary Practice Management Software Platform, Covetrus Pulse™** Covetrus launched Covetrus Pulse™, a new cloud-based practice management software platform designed to streamline operations for veterinary practices in North America.
- **Q1 2025: Banfield Pet Hospital Opens 50th New Clinic in North America Since 2023** Banfield Pet Hospital celebrated the opening of its 50th new clinic in North America since 2023, reflecting ongoing expansion in veterinary care access.
- **Q2 2025: Zoetis Receives FDA Approval for Solensia® (frunevetmab) for the Control of Osteoarthritis Pain in Cats in the United States** Zoetis received FDA approval for Solensia®, a monoclonal antibody therapy for the control of osteoarthritis pain in cats, further expanding its U.S. companion animal therapeutics portfolio.
- **Q2 2025: Elanco Animal Health Announces $200 Million Investment to Expand Manufacturing Facility in Indiana** Elanco Animal Health announced a $200 million investment to expand its manufacturing facility in Indiana, aimed at increasing production capacity for veterinary medicines.
- **Q2 2025: IDEXX Laboratories Acquires ezyVet, a Leading Cloud-Based Veterinary Practice Management Software Provider** IDEXX Laboratories acquired ezyVet, a cloud-based veterinary practice management software provider, to enhance its digital solutions offering for North American veterinary practices.

## Report Scope

| MARKET SIZE 2024 | 12.12(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 12.58(USD Billion) |
| MARKET SIZE 2035 | 17.54(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.41% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Mars Petcare (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Merck Animal Health (US), VCA Inc. (US), PetSmart (US), Nestle Purina PetCare (US), Idexx Laboratories (US) |
| Segments Covered | Service Type, Animal Type, Product Type, End User |
| Key Market Opportunities | Integration of telemedicine and digital health solutions in the North America Veterinary Care Market. |
| Key Market Dynamics | Rising demand for advanced veterinary services drives innovation and competition in the North America Veterinary Care Market. |
| Countries Covered | US, Canada |

## Frequently Asked Questions

**Q: What is the projected market valuation of the North America Veterinary Care Market by 2035?**
A: The North America Veterinary Care Market is projected to reach a valuation of 17.54 USD Billion by 2035.

**Q: What was the market valuation of the North America Veterinary Care Market in 2024?**
A: In 2024, the market valuation of the North America Veterinary Care Market was 12.12 USD Billion.

**Q: What is the expected CAGR for the North America Veterinary Care Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the North America Veterinary Care Market during the forecast period 2025 - 2035 is 3.41%.

**Q: Which segment is projected to have the highest valuation in the North America Veterinary Care Market by 2035?**
A: By 2035, the Diagnostic Services segment is projected to reach a valuation of 6.54 USD Billion.

**Q: What are the key players in the North America Veterinary Care Market?**
A: Key players in the North America Veterinary Care Market include Mars Petcare, Zoetis, Boehringer Ingelheim, and Elanco Animal Health.

**Q: How much is the Companion Animals segment expected to grow by 2035?**
A: The Companion Animals segment is expected to grow from 5.0 USD Billion in 2024 to 7.0 USD Billion by 2035.

**Q: What is the projected valuation for the Emergency Care segment by 2035?**
A: The Emergency Care segment is projected to reach a valuation of 2.6 USD Billion by 2035.

**Q: What is the expected growth for the Pet Food segment in the North America Veterinary Care Market?**
A: The Pet Food segment is expected to grow from 3.0 USD Billion in 2024 to 4.0 USD Billion by 2035.

**Q: Which end user segment is anticipated to see the most growth by 2035?**
A: The Veterinary Clinics segment is anticipated to grow from 3.63 USD Billion in 2024 to 5.25 USD Billion by 2035.

**Q: What is the projected valuation for the Vaccines segment by 2035?**
A: The Vaccines segment is projected to reach a valuation of 2.1 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/north-america-veterinary-care-market-17747*